U.S. pharma big copyright scrapped two experimental weight loss pills previous yr—a the moment-everyday capsule, lotiglipron, as a result of elevated liver enzymes plus a twice-day-to-day tablet, danuglipron, on account of potent Unwanted effects—but CEO Albert Bourla has stated the